Hepatitis C

Top Story

with Niraj C. Patel, MD, MS

with Niraj C. Patel, MD, MS
Infectious Disease News, July 2019
In the Journals

Harvoni joins growing DAA options for younger patients with HCV

July 17, 2019
Harvoni joins other direct-acting antivirals in demonstrating safety and high efficacy in younger pediatric patients with chronic hepatitis C, specifically those aged 3…

Telemedicine takes focus in study of HCV treatment in methadone centers

July 17, 2019
With $7 million from the Patient-Centered Outcomes Research Institute, seven opioid treatment programs announced entry into an ongoing study of telemedicine for…
In the JournalsPerspective

Pharmacist-driven HCV treatment model yields high SVR rates

July 14, 2019
Clinical pharmacist-delivered hepatitis C virus therapy yields high rates of SVR, according to findings published in Open Forum Infectious Diseases. “In order to…
More Headlines »

Five Points for the Community Clinician: Diagnosing and Managing Invasive Mold Infections

This activity is supported by an educational grant from Astellas Pharma Global Development, Inc.

Invasive mold infections are a significant cause of morbidity and mortality due to the increasing population of…
More »
In the Journals

Providing DAAs to PWID in primary care increases uptake, cure rates

July 1, 2019
Providing direct acting antivirals, or DAAs, for hepatitis C virus infection in primary care settings significantly…
More »
Meeting News

Cost-effective liver cancer screening after HCV requires better risk cutoffs

April 13, 2018
More »